Showing 3391-3400 of 23180 results for "".
The Eden Alternative: Reinventing Long Term Care
https://reachmd.com/programs/clinicians-roundtable/the-eden-alternative-reinventing-long-term-care/1485/Hear Dr. WIlliam H. Thomas, the founder of the Eden Alternative, as he discusses how Eden Homes are reinventing the long-term care environment.Acute Decompensated Heart Failure
https://reachmd.com/programs/clinicians-roundtable/acute-decompensated-heart-failure/138/Dr. Anderson reviews the patient types presenting to the emergency room with signs of heart failure, and how to determine who should be admitted for treatment.Anesthesiology Pre-op Evaluations
https://reachmd.com/programs/clinicians-roundtable/anesthesiology-pre-op-evaluations/126/Dr. Wafai discusses patient profiles and necessary information to make a proper evaluation prior to receiving anesthesia.COVID-19 in Pregnant Individuals and Children: Vaccine Access and Advocacy
https://reachmd.com/programs/clinicians-roundtable/covid-19-in-pregnant-and-pediatric-populations-vaccine-access-and-advocacy/36415/Even after the emergency phase of the pandemic, COVID-19 continues to pose risks for pregnant women, postpartum individuals, and young children, which is why enhancing representation in research and access to care is so pivotal. Join Dr. Flor Muñoz to hear about strategies for improving vaccine confDiagnosing & Treating Neurocognitive Disorders in the Psychiatric Setting
https://reachmd.com/programs/neurofrontiers/diagnosing-treating-neurocognitive-disorders-in-the-psychiatric-setting/15385/How can we accurately diagnose neurocognitive disorders? Tune in to this recap from the 2023 American Psychiatric Association Annual Meeting.Managing High-Risk Osteoporosis: Post-Hoc Findings on Abaloparatide
https://reachmd.com/programs/frontlines-osteoporosis/managing-high-risk-osteoporosis-post-hoc-findings-on-abaloparatide/32345/Abaloparatide has been gaining attention as a treatment option for patients with osteoporosis at very high risk of fracture. A recent post-hoc analysis of the ACTIVE trial, which examined how abaloparatide compares to teriparatide and placebo in reducing fractures and improving bone mineral density,Chasing Answers: Is There a Link Between Exercise & Psoriasis?
https://reachmd.com/programs/spotlight-psoriasis/chasing-answers-is-there-a-link-between-exercise-and-psoriasis/12255/Can cardiorespiratory exercise prevent the onset of autoimmune diseases such as psoriasis?Challenges in AI-Driven Dermatology: Understanding Current Limitations
https://reachmd.com/programs/clinicians-roundtable/challenges-in-ai-driven-dermatology-understanding-current-limitations/32934/While artificial intelligence tools for hair loss treatment are rapidly evolving, limitations on time, cost, and data integration still exist.Exploring the Gut-Skin Axis in Psoriasis
https://reachmd.com/programs/Audioabstracts/gut-skin-axis-psoriasis/39683/Psoriasis may present on the skin, but emerging evidence suggests its inflammatory roots extend deep into the gut. In this AudioAbstract, Ryan Quigley reviews findings from a comprehensive article published in Frontiers in Microbiology, examining how microbial dysbiosis, impaired barrier integrity,Expanding the Role of Hormonal Therapy and Isotretinoin in Acne Care
https://reachmd.com/programs/clinicians-roundtable/hormonal-isotretinoin-acne-care/49089/Explore when and how hormonal therapy and isotretinoin can optimize acne outcomes with Dr. John Barbieri. Challenging outdated assumptions, Dr. Barbieri advocates for broader use of hormonal therapies like spironolactone, clascoterone, and oral contraceptives beyond the traditional subset of adult w